Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $7.14 +0.07 (+0.99%) As of 09/16/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics Stock Price Performance The Aerovate Therapeutics (AVTE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 89.32%, with a year-to-date return of -92.30%. In the past month, the stock has increased 5.47%, reflecting recent market activity. As of the latest close, Aerovate Therapeutics traded at $7.07 with a market cap of $204.92 million and volume of 130,873 shares. Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-7.99%1 Month Performance+5.47%3 Month Performance+2.15%Year-To-Date Performance-92.30%1 Year Performance-89.32% AVTE Stock Chart for Wednesday, September, 17, 2025 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/17/2025$7.07$7.14+0.99%$7.35$6.9136,083 shs$206.95 million09/16/2025$7.70$7.07-8.18%$7.80$6.99130,873 shs$204.92 million09/15/2025$7.70$7.70$7.96$7.5537,906 shs$223.18 million09/12/2025$7.58$7.76+2.44%$7.94$7.6653,233 shs$224.92 million09/11/2025$7.62$7.58-0.59%$7.75$7.5035,897 shs$219.56 million09/10/2025$7.48$7.62+1.87%$7.67$7.1830,588 shs$220.87 million09/09/2025$7.77$7.48-3.73%$7.94$7.3353,005 shs$216.81 million09/08/2025$7.77$7.77$8.08$7.6157,825 shs$225.21 million09/05/2025$7.50$7.78+3.80%$7.87$7.3246,506 shs$225.50 million09/04/2025$7.62$7.50-1.64%$7.98$7.4350,121 shs$217.24 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/03/2025$7.90$7.62-3.54%$8.11$7.5778,629 shs$220.87 million09/02/2025$7.90$7.90$8.12$7.7947,960 shs$228.98 million09/01/2025$7.90$7.90$8.12$7.7947,960 shs$228.98 million08/29/2025$7.95$7.95$8.38$7.8368,897 shs$230.43 million08/28/2025$8.03$7.95-1.00%$8.38$7.8368,897 shs$230.43 million08/27/2025$7.90$8.03+1.65%$8.12$7.6973,960 shs$232.75 million08/26/2025$8.23$7.90-4.01%$8.21$7.65111,930 shs$228.98 million08/25/2025$8.23$8.23$8.30$7.18124,811 shs$238.55 million08/22/2025$7.36$7.38+0.27%$7.45$6.71100,416 shs$213.91 million08/21/2025$7.36$7.36$7.64$7.2884,262 shs$213.33 million08/20/2025$7.50$7.36-1.87%$7.64$7.2884,262 shs$213.33 million08/19/2025$7.36$7.50+1.90%$7.62$7.25106,061 shs$217.39 million08/18/2025$7.36$7.36$7.39$6.67186,080 shs$213.33 million Related Companies Immunome Stock Chart Taysha Gene Therapies Stock Chart BGM Group Stock Chart uniQure Stock Chart Phathom Pharmaceuticals Stock Chart Anavex Life Sciences Stock Chart ProKidney Stock Chart Valneva Stock Chart Oculis Stock Chart Niagen Bioscience Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
